期刊文献+

艰难梭菌临床分离株5年前后耐药性变化 被引量:9

Ribotyping and antimicrobial resistance patterns of Clostridium difficile during two periods with an interval of 5 years
下载PDF
导出
摘要 目的了解艰难梭菌临床分离株5年前后核糖体分型和对常用抗菌药物耐药性的变化。方法分别收集复旦大学附属华山医院2007年8月至2008年7月和2012年8月至2013年7月艰难梭菌临床分离株,用琼脂稀释法测定甲硝唑等10种抗菌药物对艰难梭菌临床分离株的抗菌活性;PCR法检测艰难梭菌的毒素基因tcdA、tcdB、cdtA和cdtB;核糖体分型法对菌株进行分子分型。结果 2007年8月—2008年7月与2012年8月—2013年7月分别获得艰难梭菌产毒株74株和64株。5年前产毒株中A+B+和A-B+分别占66.2%和31.1%,二元毒素(A+B+CDT+)占2.7%;5年后A+B+和A-B+菌株分别占65.6%和34.4%。5年前细菌核糖体分型以017型最多见,占24.3%,5年后以H型(18.8%)最多见。所有临床分离株对甲硝唑和万古霉素均呈高度敏感,但对克林霉素、四环素和夫西地酸等多种抗菌药物的耐药率较5年前上升。对氟喹诺酮类、大环内酯类和林可酰胺类药物呈多重耐药的菌株从28.3%上升至32.8%。结论艰难梭菌临床分离株中A+B+菌株仍约占2/3,但核糖体分型由017型最多见转为以H型最多见。所有艰难梭菌菌株对甲硝唑和万古霉素均呈敏感,但对四环素等多种抗菌药物耐药率较5年前增高。 Objective To investigate the changing patterns of ribotypes and antimicrobial resistance of Clostridium difficile strains collected from Huashan Hospital of Fudan University after 5 years. Methods C. difficile isolates collected during the periods from August 2(107 to July 2008 and August 2(/12 to July 2013 were analyzed and compared for their antibiotic suscepti- bility patterns using agar dilution method. PCR ribotyping and real-time PCR were performed to detect tcdA, tcdB, ctdA, and cdtB genes. Results Seventy-four toxigenic C. difficile strains were collected during the period from August 2007 to July 2008 and and 64 strains were obtained from August 2012 to July 2013. Among the 74 strains,49 were toxin A+ B+ (66.2%), 23 toxin A 13 + (31.1), and2 toxin A + 13 +CDT + (2.7).The dominant PCR ribotype was 017 (24.3/00). Five years later, 65.6 of the 64 strains belonged to toxin A+ B+ . PCR ribotype H (18.8) was the dominant clone. Both sets of strains were highly susceptible to metronidazole and vancomycin. However, the strains resistant to elindamyein, tetracycline and fusidic acid in- creased after 5 years. The strains resistant to multiple drugs including fluoroquinolones, macrolides and lincosamides increased from28.3o/00 to 32.8 after 5 years. Conclusions C. difficile A+ B+ strains still play a major role in CDI, accounting for about 2/3 of the isolates. PCR ribotype H has replaced 017 as the dominant clone. All the strains are still susceptible to metron- idazole and vancomycin,but the resistance to tetracycline and fu sidic acid gets higher than 5 years before.
出处 《中国感染与化疗杂志》 CAS 北大核心 2014年第2期116-120,共5页 Chinese Journal of Infection and Chemotherapy
基金 国家自然科学基金资助项目(30973594 81101292) 上海市浦江人才计划(10PJ1401800)
关键词 艰难梭菌 核糖体分型 抗菌药物耐药性 Clostridium difficile ribotype antimicrobial resistance
  • 相关文献

参考文献22

  • 1Kelly CP, LaMont JT. Clostridium difficile more difficult than ever[J]. N Engl J Med, 2008, 359(18) : 1932-1940.
  • 2Bauer MP,Notermans DW, van Benthem BH,et al. Clostrid- ium difficile infection in Europe: a hospital based survey [J]. Lancet,2011,377 (9759) :63-73.
  • 3Huang H,Wu S,Wang M,et al. Molecular and clinical charae teristics of Clostridium difficile infection in a University Hospital in Shanghai, China [J]. Clin Infect Dis, 2008, 47 (12) : 1606-1608.
  • 4陈云波,吴微珍,鲁海峰,杨介钻,王保红,孔海深,李兰娟.艰难梭菌相关性腹泻患者50例临床特征及其病原菌耐药性分析[J].浙江医学,2010,0(11):1632-1634. 被引量:7
  • 5Oka K,Osaki T, Hanawa T,et al. Molecular and microbiologi- cal characterization of Clostridium difficile isolates from single, relapse, and reinfection cases[J]. J Clin Microbiol, 2012,50(3) :915- 921.
  • 6IlchmannC, Zaiss NH, Speicher A, et al. Comparison of resist- ance against erythromycin and moxifloxacin, presence of bi- nary toxin gene and PCR ribotypesin Clostridium difficile i- solates from 1990 and 2008[J]. Eur J Clin Mierobiol Infect Dis,2010,29(12) :1571-1573.
  • 7黄海辉,吴湜,朱德妹,吴菊芳,王明贵,张婴元.临床分离艰难梭菌188株的耐药性研究[J].中国感染与化疗杂志,2011,11(1):1-5. 被引量:13
  • 8SurawiczCM,Brandt LJ ,Binion DG,et ah Guidelines for diag- nosis, treatment, and prevention of Clostridium difficile in fections[J]. Am J Gastroenterol,2013,108(4) :478- 498.
  • 9PelaezT,Alcald L, Alonso R, et al. In vitro activity of ramo- planin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole[J]. Antimicrob Agents Chemother, 2005, 49 (3):1157 -1159.
  • 10Stubbs SL,Brazier JS,O'Neill GL,et al. PCR targeted to the 16S- 23S rRNA gene intergenic spacer region of Clostridium dif ficile and construction of a ferent PCR ribotypes[J]. J Clin 463. library consisting of 116 dif Microbiol, 1999,37 ( 2 ) : 463.

二级参考文献43

  • 1Poutanen S M,Simor A E.Clostridium difficile-associated diarrhea in adults[J].CMAJ,2004,171 (1):51-58.
  • 2Kuijper E J,Coignard B,T(u)ll P.Emergence of clostridium difficile-associated disease in north America and Europe[J].Clin Microbiol Infect,2006,12(Suppl 6):2-18.
  • 3Clabots C R,Gerding S J,Olson M M,et al.Detection of asymptomatic clostridium difficile carriage by an alcohol shock procedure[J].J Clin Microbiol,1989,27(10):2386-2387.
  • 4Kato H,Ou C Y,Kato N,et al.Identification of toxigenic clostridium difficile by the polymerase chain reaction[J].J Clin Microbiol,1991,29(1):33-37.
  • 5Kato H,Kato N,Watanabe K,et al.Identification of toxin A-negative,toxin B-positive clostridium difficile by PCR[J].J Clin Microbiol,1998,36(8):2178-2182.
  • 6McDonald L C,Coignard B,Dubberke E,et al.Recommendations for surveillance of clostridium difficile-associated disease[J].Infect Control Hosp Epidemiol,2007,28(1):140-145.
  • 7Indra A,Schmid D,Huhulescu S,et al.Characterization of clinical clostridium difficile isolates by PCR ribotyping and detection of toxin genes in Austria,2006-2007[J].J Med Microbiol,2008,57:702-708.
  • 8Mcfarland LV.Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients[J].Am J Infect Control,1995,23(5):295-305.
  • 9Mutlu E,Wroe A J,Karla S H,et al.Molecular characterization and antimicrobial susceptibility patterns of clostridium difficile strains isolated from hospitals in south-east Soctland[J].J Med Microbiol,2007,56:921-929.
  • 10Martin H,Willey B,Low D E,et al.Characterization of clostridium difficile strains isolated from patients in Ontario,Canada,from 2004 to 2006[J].J Microbiol,2008,46(9):2999-3004.

共引文献32

同被引文献70

  • 1李凤霞.对克林霉素临床应用的安全性研究[J].当代医药论丛,2014,12(14):140-141. 被引量:2
  • 2王明贵.喹诺酮类抗菌药的耐药性及质粒介导耐药机制[J].中华医学杂志,2006,86(9):645-647. 被引量:35
  • 3Sun X, Hirota S A. The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection[ J]. Mol Immunol, 2015,63(2) :193-202.
  • 4Simor A E. Diagnosis, management, and prevention of clostridium difficile infection in long-term care facilities: a review[J]. J Am Geriatr Soe, 2010,58(8):1556- 1564.
  • 5Huang H, Wu S, Chen R, et al. Risk factors of Clostrid- ium difficile infections among patients in a university hos- pital in Shanghai, China[ J]. Anaerobe, 2014,30 (12) : 65 -69.
  • 6Kelly C P, LaMont J T. Clostridium diffieile-more diffi- cult than ever[J]. N Engl J Med, 2008,359(18) :1932- 1940.
  • 7Lyras D, OConnor J R, Howarth P M, et al. Toxin B is essential for virulence of Clostridium difficile[ J ]. Nature, 2009,458 (7242) : 1176-1179.
  • 8Vedantam G, Clark A, Chu M, et al. Clostridium diffi- cile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host re- sponse[ J ]. Gut Microbes, 2012,3 (2) : 121-134.
  • 9Lyerly D M, Saum K E, MacDonald D K, et al. Effects of Clostridium difficile toxins given intragastrically to ani- mals[J]. Infect Immun, 1985,47(2) :349-352.
  • 10Goulding D, Thompson H, Emerson J, et al. Distinctive profiles of infection and pathology in hamsters infected with clostridium difficile strains 630 and bl [ J]. Infect Immun, 2009,77(12) :5478-5485.

引证文献9

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部